US 7332612
Amorphous and crystalline forms of losartan potassium and process for their preparation
granted A61PA61P9/12
Quick answer
US patent 7332612 (Amorphous and crystalline forms of losartan potassium and process for their preparation) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P9/12